The CNIB Foundation Announces New Partnership with IrisVision

The CNIB Foundation has signed a new partnership agreement with IrisVision, global leader in digital vision technologies.

IrisVision’s visual assistive device allows users to access and amplify their limited sight. The wearable device is FDA registered, and helps users with a variety of eye conditions including age-related macular degeneration, Stargart disease, and glaucoma.

“IrisVision redefines possibilities for those living with vision impairment and aims to not only provide sight, but to connect people with their world,” says Ammad Khan, CEO of IrisVision. “We are proud to be partnering with the CNIB Foundation, an organization that supports Canadians with sight loss from coast to coast. We’ve had thousands of success stories in the United States and are looking forward to expanding our resources to the 1.5 million Canadians living with low vision.”

Through this partnership, people with sight loss across the country will have exclusive access to IrisVision’s products as soon as they launch through all of the CNIB Foundation’s enterprises, including Shop CNIB, CNIB Frontier Accessibility and its affiliate organization, Vision Loss Rehabilitation Canada.

Click HERE for the full press release.

Featured Posts

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read More

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read More

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read More

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Applications for the 2023 Transitions Change Agent Program Now Open Through December 31, 2022

Become a Change Agent and make a difference with your peers and patients!

Learn More

Swarovski and EssilorLuxottica Announce Ten-year Licensing Agreement

Swarovski and EssilorLuxottica announce that they have signed an exclusive license agreement for the design, manufacture and worldwide distribution of Swarovski Eyewear.

Read more

Industry Professionals and Trainers Joined Transitions Optical for “The Studio” Educational Event, 2nd Edition

Transitions Optical gathered over 80 industry professionals for a one-of-a-kind learning train the trainer event—Transitions® The Studio—on November 8, 2022.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Read more

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more